Clinical Study
Helical Tomotherapy for Inoperable Breast Cancer: A New Promising Tool
Table 4
Treatment characteristics and results.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AJCC cancer staging manual, seventh edition (2010), WB: whole breast, CCT: concomitant chemotherapy, CTCAE: Common Toxicity Criteria for Adverse Events v.4, †baseline evaluation before all treatments, delivered radiation dose, ‡cardiovascular and/or pulmonary and/or hematological toxicity, *residual invasive malignant epithelial cells, interpretation at the Institut Curie of the concept proposed by Sataloff and colleagues (details in article), PR: partial response. |